Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How long does the import and export licence application process generally take?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q483 · Category J: Cross-border pharmaceuticals and industry practice (Q451-Q500)
According to the requirements of the Drug Office, Department of Health, import and export licence applications generally take around 6 to 8 working days to process after complete information has been submitted. Processing may take longer if information is incomplete or special categories of medicines are involved. Applicants should prepare detailed medicine information, evidence of the purpose of import or export, and the relevant licences in advance. Rengangyongsheng (Hong Kong) Limited recommends starting the application 1 month in advance and maintaining communication with the Department of Health during this period to ensure that any additional information is submitted promptly and business operations are not delayed.

📘 Regulatory basis

Drug Office, Department of Health: Application process and indicative timelines for import and export licences

📗 Drew Tang's recommendations

Prepare complete documentation in advance and plan the schedule appropriately to avoid delays to goods movement caused by approval delays.

📕 Risk notice

Incomplete information or insufficient qualifications will extend the approval process and affect the fulfilment of commercial contracts.

Back to Category J: Cross-border Medicines and Industry Practice (Q451-Q500) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗